CA2509035C - Contrast media formulations having improved biological tolerance - Google Patents

Contrast media formulations having improved biological tolerance Download PDF

Info

Publication number
CA2509035C
CA2509035C CA2509035A CA2509035A CA2509035C CA 2509035 C CA2509035 C CA 2509035C CA 2509035 A CA2509035 A CA 2509035A CA 2509035 A CA2509035 A CA 2509035A CA 2509035 C CA2509035 C CA 2509035C
Authority
CA
Canada
Prior art keywords
formulation
tris
carboxylic acid
iosimenol
contrast medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2509035A
Other languages
English (en)
French (fr)
Other versions
CA2509035A1 (en
Inventor
Milos Sovak
Allen L. Seligson
Ronald C. Terry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biophysica Foundation
Original Assignee
Biophysica Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophysica Foundation filed Critical Biophysica Foundation
Publication of CA2509035A1 publication Critical patent/CA2509035A1/en
Application granted granted Critical
Publication of CA2509035C publication Critical patent/CA2509035C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA2509035A 2002-12-12 2003-11-07 Contrast media formulations having improved biological tolerance Expired - Lifetime CA2509035C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US43287902P 2002-12-12 2002-12-12
US60/432,879 2002-12-12
US10/701,586 US7250153B2 (en) 2002-12-12 2003-11-05 Contrast media formulations having improved biological tolerance
US10/701,586 2003-11-05
PCT/US2003/035762 WO2004054637A2 (en) 2002-12-12 2003-11-07 Contrast media formulations having improved biological tolerance

Publications (2)

Publication Number Publication Date
CA2509035A1 CA2509035A1 (en) 2004-07-01
CA2509035C true CA2509035C (en) 2011-07-19

Family

ID=34107426

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2509035A Expired - Lifetime CA2509035C (en) 2002-12-12 2003-11-07 Contrast media formulations having improved biological tolerance

Country Status (18)

Country Link
US (1) US7250153B2 (enExample)
EP (1) EP1575621B1 (enExample)
JP (1) JP2006509841A (enExample)
KR (1) KR101067159B1 (enExample)
CN (1) CN1738651A (enExample)
AT (1) ATE447416T1 (enExample)
AU (1) AU2003295442B2 (enExample)
CA (1) CA2509035C (enExample)
CY (1) CY1110105T1 (enExample)
DE (1) DE60329939D1 (enExample)
DK (1) DK1575621T3 (enExample)
ES (1) ES2333863T3 (enExample)
IL (1) IL169119A (enExample)
NO (1) NO332350B1 (enExample)
NZ (1) NZ541139A (enExample)
PT (1) PT1575621E (enExample)
SI (1) SI1575621T1 (enExample)
WO (1) WO2004054637A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070015517A (ko) * 2004-03-11 2007-02-05 말린크로트, 인코포레이티드 요오드화된 단량체 및 이량체의 혼합물을 포함하는 ｘ-선조영제 제형
FR2899581B1 (fr) * 2006-04-07 2008-06-27 Guerbet Sa Procede d'atomisation du ioxilan
WO2009091758A1 (en) 2008-01-14 2009-07-23 Mallinckrodt Inc. Process for the preparation of iosimenol
RU2012138280A (ru) * 2010-03-23 2014-04-27 ДжиИ Хелткер АС Получение стабилизированной диагностической композиции для рентгеновского исследования

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR222337A1 (es) * 1978-07-04 1981-05-15 Nyegaard & Co As Procedimiento para preparar una solucion esteril inyectable fisiologicamente aceptable de un agente de contraste de rayos x
US5698739A (en) * 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
KR19990022943A (ko) * 1995-06-16 1999-03-25 밀로스 소박 비이온성 조영제로서의 포르밀 유도체
DE19648650C2 (de) 1996-01-29 1998-07-02 Schering Ag Puffersysteme und deren Verwendung zur Stabilisierung pharmazeutischer Zubereitung

Also Published As

Publication number Publication date
SI1575621T1 (sl) 2010-01-29
CY1110105T1 (el) 2015-01-14
US20050025711A1 (en) 2005-02-03
NO20053343D0 (no) 2005-07-08
AU2003295442A1 (en) 2004-07-09
NO20053343L (no) 2005-09-08
WO2004054637A3 (en) 2004-09-16
WO2004054637A2 (en) 2004-07-01
US7250153B2 (en) 2007-07-31
IL169119A0 (en) 2007-07-04
PT1575621E (pt) 2009-11-13
CN1738651A (zh) 2006-02-22
CA2509035A1 (en) 2004-07-01
EP1575621B1 (en) 2009-11-04
EP1575621A4 (en) 2008-11-26
KR20050088312A (ko) 2005-09-05
ATE447416T1 (de) 2009-11-15
DE60329939D1 (de) 2009-12-17
KR101067159B1 (ko) 2011-09-22
ES2333863T3 (es) 2010-03-02
NO332350B1 (no) 2012-09-03
EP1575621A2 (en) 2005-09-21
JP2006509841A (ja) 2006-03-23
DK1575621T3 (da) 2009-12-14
AU2003295442B2 (en) 2008-11-06
IL169119A (en) 2010-06-16
NZ541139A (en) 2008-07-31

Similar Documents

Publication Publication Date Title
EP0675738B1 (en) Aqueous injectable formulations useful for radio-diagnosis comprising iodinated aromatic compounds used as x-ray contrast media
EP1725268B1 (en) X-ray contrast formulation comprising a mixture of iodinated monomer and dimer
CA2509035C (en) Contrast media formulations having improved biological tolerance
EP1411992B1 (en) Ionic and non-ionic radiographic contrast agents for use in combined x-ray and nuclear magnetic resonance diagnostics
EP1792894B1 (en) Contrast agents
HU220867B1 (en) Pharmaceutical compositions as a solution, containing bis-triazole derivatives and process for producing them
EP1798219A1 (en) Contrast agents
GB2465663A (en) X-ray contrast agent compositions comprising an iodinated X-ray contrast agent and ethylenediamine-N,N-disuccinic acid
US7662859B2 (en) Contrast agents
KR20150134346A (ko) 진단 조성물을 제조하기 위한 방법 및 시약
KR20150014526A (ko) 고농도의 조영제를 포함하여 높은 조영 증강 효과를 나타내는 조영제 조성물

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20231107